Clinical Trials on Advanced Cancers in United States

Total 25052 results

University of California, Los Angeles
University of California, San Francisco; University of California, Irvine

Active, not recruiting

UC Health Care Planning Study

Advanced Cancer | Advance Care Planning | Advance Directives

United States
M.D. Anderson Cancer Center

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Advanced Cancers

United States
M.D. Anderson Cancer Center
Gateway for Cancer Research; Theravalues, Inc.

Completed

Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study

Advanced Cancers

United States
M.D. Anderson Cancer Center
Foundation Medicine

Completed

Genomic Profiling Assay in Phase I

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Perception of Palliative Care Encounter

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Occupational Therapy in Palliative Care

Advanced Cancers

United States
M.D. Anderson Cancer Center
Yukiguni Maitake Company Ltd.

Terminated

Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide

Advanced Cancers

United States
Novartis Pharmaceuticals

Recruiting

Ribociclib (LEE011) Rollover Study for Continued Access

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

Spain, Taiwan, United States, Singapore, France
STORM Therapeutics LTD

Recruiting

Oral Administration of STC-15 in Subjects With Advanced Malignancies

Cancer | Advanced Solid Tumor | Advanced Cancer

United States
Janssen Research & Development, LLC

Completed

A First in Man Study of MABp1 in Patients With Advanced Cancers

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Cetuximab

Advanced Cancers

United States
BiOneCure Therapeutics Inc.

Recruiting

A Study in Patients With Advanced Cancers

Cancer | Advanced Solid Tumor | Advanced Cancer | Oncology

United States
M.D. Anderson Cancer Center
Pfizer

Completed

Dasatinib and Crizotinib in Advanced Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

Advanced Cancers

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

HAI Abraxane With Gemcitabine and Bevacizumab

Advanced Cancers

United States
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Azacytidine and Valproic Acid in Patients With Advanced Cancers

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

LY2275796 in Advanced Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center
American Cancer Society, Inc.

Completed

Cordotomy for Refractory Cancer Pain

Pain | Advanced Cancers

United States
Yale University
Celgene Corporation

Terminated

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Advanced Solid Cancers

United States
Yale University
Agennix

Completed

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Advanced Cancers

United States
M.D. Anderson Cancer Center
GlaxoSmithKline; National Comprehensive Cancer Network

Completed

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

Solid Tumors | Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Registry Study for Personalized Cancer Therapy

Solid Tumors | Advanced Cancers

United States
Case Comprehensive Cancer Center

Completed

Online Information and Support for Distance Caregivers

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

The Role of the EKG in Anticancer Drug Development

Advanced Cancer

United States
M.D. Anderson Cancer Center
European Commission

Completed

Rational Therapeutics Based on Matched Tumor and Normal Tissue

Advanced Cancers

United States, Spain, France, Israel
Semafore Pharmaceuticals
SignalRX Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors (SF112600106)

Cancer | Advanced or Metastatic Solid Tumors | Solid Cancers

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Temsirolimus In Phase 0

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Study of Temsirolimus, Topotecan, and Bortezomib

Advanced Cancer

United States
Massachusetts General Hospital

Completed

Using Video Images to Improve Advance Care Planning in Patients With Cancer

Advanced Cancer

United States
Memorial Sloan Kettering Cancer Center
Peter MacCallum Cancer Centre, Australia; Fordham University; Calvary Hospital...

Completed

Measuring Hope and Hopelessness in Cancer

Advanced Cancer

United States
Vanderbilt-Ingram Cancer Center
National Institutes of Health (NIH)

Active, not recruiting

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
Dana-Farber Cancer Institute

Completed

Videos for Advance Care Planning in Young Adults

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Bevacizumab in Multiple Phase I Combinations

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Locus of Control and Spirituality in Palliative Care Patients

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Message: Study of Patients' Perception of Physician's Compassion

Advanced Cancer

United States
Scottsdale Healthcare
Translational Genomics Research Institute; National Foundation for Cancer Research

Completed

An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Pralatrexate in Advanced Malignancies

Solid Tumors | Advanced Cancers

United States
Teon Therapeutics, Inc.
Merck Sharp & Dohme LLC

Terminated

TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88)

Cancer | Advanced Solid Tumor | Advanced Cancer | Oncology

United States
Alaunos Therapeutics

Completed

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Advanced Cancer

United States

Clinical Trials on Advanced Cancers in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations